ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2021
National Influenza Annual Report, Canada, 2020-2021, in the global context.
Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 21 citations in OpenAlex.
- An evaluation of barriers and facilitators to implementing multiplex rapid antigen testing for SARS-CoV-2 and influenza A and B in congregate living settings.Frontiers in public health · 2025Article
- Effect of the COVID-19 Pandemic on Respiratory Diseases and Their Economic Impacts.Pathogens (Basel, Switzerland) · 2024Review
- Influenza vaccine coverage and factors associated with non-vaccination among caregiving and care-receiving adults in the Canadian Longitudinal Study on Aging (CLSA).BMC public health · 2024Article
- AMMI Canada 2023 update on influenza: Management and emerging issues.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2023Article
- Establishing Pandemic Influenza Severity Assessment (PISA) parameters and thresholds for Canada's FluWatch program.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2023Article
- National Influenza Annual Report, Canada, 2022-2023: Canada's first fall epidemic since the 2019-2020 season.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2023Article
- Asymptomatic surveillance testing for COVID-19 in health care professional students: lessons learned from a low prevalence setting.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023Article
- Why Did Home Care Personal Support Service Volumes Drop During the COVID-19 Pandemic? The Contributions of Client Choice and Personal Support Worker Availability.Health services insights · 2023Article
- National Influenza Annual Report, Canada, 2021-2022: A brief, late influenza epidemic.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2022Article
- 2021-2022 AMMI Canada guidance on the use of antiviral drugs for influenza in the COVID-19 pandemic setting in Canada.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2022Article
- Article
- National FluWatch mid-season report, 2021-2022: Sporadic influenza activity returns.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2022Article
- Article
- Mitigating co-circulation of seasonal influenza and COVID-19 pandemic in the presence of vaccination: A mathematical modeling approach.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During the 2020-2021 Canadian influenza season, no community circulation of influenza occurred. Only 69 positive detections of influenza were reported, and influenza percent positivity did not exceed 0.1%. Influenza indicators were at historical lows compared with the previous six seasons, with no laboratory-confirmed influenza outbreaks or severe outcomes being reported by any of the provinces and territories. Globally, influenza circulation was at historically low levels in both the Northern and the Southern Hemispheres. The decreased influenza activity seen in Canada and globally is concurrent with the implementation of non-pharmaceutical public health measures to mitigate the spread of the coronavirus disease 2019 (COVID-19). Although it is difficult to predict when influenza will begin to re-circulate, given the increased COVID-19 vaccination and the relaxation of public health measures, an influenza resurgence can be expected and may be more severe or intense than recent seasons. Influenza vaccination, along with non-pharmaceutical public health measures, continues to remain the best method to prevent the spread and impact of influenza. Public health authorities need to remain vigilant, maintain surveillance and continue to plan for heightened seasonal influenza circulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.